CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹25,644 Cr | ₹21,439 Cr | ₹18,057 Cr | ₹15,669 Cr | ₹13,537 Cr |
What is the latest Profit & Loss Account Balance ratio of CIPLA ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2025 | ₹25,644 Cr |
| Mar2024 | ₹21,439 Cr |
| Mar2023 | ₹18,057 Cr |
| Mar2022 | ₹15,669 Cr |
| Mar2021 | ₹13,537 Cr |
How is Profit & Loss Account Balance of CIPLA Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2025 | ₹25,644 Cr | 19.62 | |
| Mar2024 | ₹21,439 Cr | 18.73 | |
| Mar2023 | ₹18,057 Cr | 15.24 | |
| Mar2022 | ₹15,669 Cr | 15.75 | |
| Mar2021 | ₹13,537 Cr | - | |
Compare Profit & Loss Account Balance of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹123,508.6 Cr | -0.2% | -6.7% | 1.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,566.0 Cr | 1.2% | 5.3% | 0.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,594.0 Cr | -0.7% | -2.1% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,826.0 Cr | -3.2% | 4.1% | 20.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,132.0 Cr | 0.2% | -2.7% | 2% | Stock Analytics | |
| MANKIND PHARMA | ₹92,336.1 Cr | -1.3% | -8.8% | -14.7% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -0.2% |
-6.7% |
1.8% |
| SENSEX | 1.4% |
2% |
10.2% |
You may also like the below Video Courses